Reward and motivation in pain and pain relief

Nature Neuroscience

Volumn 17, Issue 10, 2014, Pages 1304-1312

  Navratilova, Edita ^a   Porreca, Frank ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT;

ANALGESIA; ANALGESIC ACTIVITY; BRAIN FUNCTION; CHRONIC PAIN; EXECUTIVE FUNCTION; HUMAN; INTRACTABLE PAIN; MOTIVATION; NEUROCHEMISTRY; NEUROIMAGING; NONHUMAN; PAIN; PLACE PREFERENCE; PRIORITY JOURNAL; REVIEW; REWARD; BRAIN; INSTRUMENTAL CONDITIONING; NERVE TRACT; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY;

BRAIN; CONDITIONING, OPERANT; HUMANS; MOTIVATION; NEURAL PATHWAYS; PAIN; PAIN MANAGEMENT; REWARD;

EID: 84917695369     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.3811     Document Type: Review

References (109)

1. Gold, M.S. & Gebhart, G.F. Nociceptor sensitization in pain pathogenesis. Nat. Med. 16, 1248-1257 (2010).
2. Fields, H.L. Pain: an unpleasant topic. Pain 6 (suppl.): S61-S69 (1999).
3. Lee, M.C. & Tracey, I. Imaging pain: a potent means for investigating pain mechanisms in patients. Br. J. Anaesth. 111, 64-72 (2013).
4. Lee, M.C. & Tracey, I. Unravelling the mystery of pain, suffering, and relief with brain imaging. Curr. Pain Headache Rep. 14, 124-131 (2010).
5. Redgrave, P., Gurney, K. & Reynolds, J. What is reinforced by phasic dopamine signals? Brain Res. Rev. 58, 322-339 (2008).
6. Woolf, C.J. & Ma, Q. Nociceptors-noxious stimulus detectors. Neuron 55, 353-364 (2007).
7. Kehlet, H., Jensen, T.S. & Woolf, C.J. Persistent postsurgical pain: risk factors and prevention. Lancet 367, 1618-1625 (2006).
8. Tracey, I. & Bushnell, M.C. How neuroimaging studies have challenged us to rethink: is chronic pain a disease? J. Pain 10, 1113-1120 (2009).
9. Johannes, C.B., Le, T.K., Zhou, X., Johnston, J.A. & Dworkin, R.H. The prevalence of chronic pain in United States adults: results of an Internet-based survey. J. Pain 11, 1230-1239 (2010).
10. van Hecke, O., Torrance, N. & Smith, B.H. Chronic pain epidemiology and its clinical relevance. Br. J. Anaesth. 111, 13-18 (2013).
11. Denk, F., McMahon, S.B. & Tracey, I. Pain vulnerability: a neurobiological perspective. Nat. Neurosci. 17, 192-200 (2014).
12. Woolf, C.J. Central sensitization: implications for the diagnosis and treatment of pain. Pain 152, S2-S15 (2011).
13. Apkarian, A.V., Baliki, M.N. & Farmer, M.A. Predicting transition to chronic pain. Curr. Opin. Neurol. 26, 360-367 (2013).
14. Bushnell, M.C., Ceko, M. & Low, L.A. Cognitive and emotional control of pain and its disruption in chronic pain. Nat. Rev. Neurosci. 14, 502-511 (2013).
15. Apkarian, A.V., Baliki, M.N. & Geha, P.Y. Towards a theory of chronic pain. Prog. Neurobiol. 87, 81-97 (2009).
16. Berger, J.V. et al. Cellular and molecular insights into neuropathy-induced pain hypersensitivity for mechanism-based treatment approaches. Brain Res. Rev. 67, 282-310 (2011).
17. Burgess, G. & Williams, D. The discovery and development of analgesics: new mechanisms, new modalities. J. Clin. Invest. 120, 3753-3759 (2010).
18. Dodick, D.W. et al. Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study. Lancet Neurol. 13, 885-892 (2014).
19. Craig, A.D. How do you feel-now? The anterior insula and human awareness. Nat. Rev. Neurosci. 10, 59-70 (2009).
20. Denton, D.A., McKinley, M.J., Farrell, M. & Egan, G.F. The role of primordial emotions in the evolutionary origin of consciousness. Conscious. Cogn. 18, 500-514 (2009).
21. Wiech, K. & Tracey, I. Pain, decisions, and actions: a motivational perspective. Front. Neurosci. 7, 46 (2013).
22. Rushworth, M.F. & Behrens, T.E. Choice, uncertainty and value in prefrontal and cingulate cortex. Nat. Neurosci. 11, 389-397 (2008).
23. Fields, H.L. in 11th World Congress on Pain (eds. Flor, H., Kalso, E. & Dostrovsky, J.O.) 449-459 (IASP Press, Seattle, 2006).
24. Sprenger, C. et al. Attention modulates spinal cord responses to pain. Curr. Biol. 22, 1019-1022 (2012).
25. Villemure, C. & Bushnell, M.C. Mood influences supraspinal pain processing separately from attention. J. Neurosci. 29, 705-715 (2009).
26. Porreca, F., Ossipov, M.H. & Gebhart, G.F. Chronic pain and medullary descending facilitation. Trends Neurosci. 25, 319-325 (2002).
27. Simons, L.E., Elman, I. & Borsook, D. Psychological processing in chronic pain: a neural systems approach. Neurosci. Biobehav. Rev. 39, 61-78 (2014).
28. Levenson, R.W. Basic emotion questions. Emot. Rev. 3, 379-386 (2011).
29. Leknes, S., Brooks, J.C., Wiech, K. & Tracey, I. Pain relief as an opponent process: a psychophysical investigation. Eur. J. Neurosci. 28, 794-801 (2008).
30. Leknes, S., Lee, M., Berna, C., Andersson, J. & Tracey, I. Relief as a reward: hedonic and neural responses to safety from pain. PLoS ONE 6, e17870 (2011).
31. Navratilova, E. et al. Pain relief produces negative reinforcement through activation of mesolimbic reward-valuation circuitry. Proc. Natl. Acad. Sci. USA 109, 20709-20713 (2012).
32. Becerra, L., Navratilova, E., Porreca, F. & Borsook, D. Analogous responses in the nucleus accumbens and cingulate cortex to pain onset (aversion) and offset (relief) in rats and humans. J. Neurophysiol. 110, 1221-1226 (2013).
33. Gerber, B. et al. Pain-relief learning in flies, rats, and man: basic research and applied perspectives. Learn. Mem. 21, 232-252 (2014).
34. King, T. et al. Unmasking the tonic-Aversive state in neuropathic pain. Nat. Neurosci. 12, 1364-1366 (2009).
35. Andreatta, M. et al. Onset and offset of aversive events establish distinct memories requiring fear and reward networks. Learn. Mem. 19, 518-526 (2012).
36. Brotis, A.G., Kapsalaki, E.Z., Paterakis, K., Smith, J.R. & Fountas, K.N. Historic evolution of open cingulectomy and stereotactic cingulotomy in the management of medically intractable psychiatric disorders, pain and drug addiction. Stereotact. Funct. Neurosurg. 87, 271-291 (2009).
37. Leknes, S. & Tracey, I. A common neurobiology for pain and pleasure. Nat. Rev. Neurosci. 9, 314-320 (2008).
38. Apkarian, A.V., Bushnell, M.C., Treede, R.D. & Zubieta, J.K. Human brain mechanisms of pain perception and regulation in health and disease. Eur. J. Pain 9, 463-484 (2005).
39. Wager, T.D. et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 303, 1162-1167 (2004).
40. Schultz, W. Updating dopamine reward signals. Curr. Opin. Neurobiol. 23, 229-238 (2013).
41. Rushworth, M.F., Noonan, M.P., Boorman, E.D., Walton, M.E. & Behrens, T.E. Frontal cortex and reward-guided learning and decision-making. Neuron 70, 1054-1069 (2011).
42. Noonan, M.P. et al. Separate value comparison and learning mechanisms in macaque medial and lateral orbitofrontal cortex. Proc. Natl. Acad. Sci. USA 107, 20547-20552 (2010).
43. Narita, M. et al. Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in mu-opioid-induced place preference. Addict. Biol. 15, 434-447 (2010).
44. Lim, S.L., ODoherty, J.P. & Rangel, A. The decision value computations in the vmPFC and striatum use a relative value code that is guided by visual attention. J. Neurosci. 31, 13214-13223 (2011).
45. Wanigasekera, V. et al. Baseline reward circuitry activity and trait reward responsiveness predict expression of opioid analgesia in healthy subjects. Proc. Natl. Acad. Sci. USA 109, 17705-17710 (2012).
46. Scott, D.J., Heitzeg, M.M., Koeppe, R.A., Stohler, C.S. & Zubieta, J.K. Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity. J. Neurosci. 26, 10789-10795 (2006).
47. Burstein, R. & Giesler, G.J. Jr. Retrograde labeling of neurons in spinal cord that project directly to nucleus accumbens or the septal nuclei in the rat. Brain Res. 497, 149-154 (1989).
48. Brischoux, F., Chakraborty, S., Brierley, D.I. & Ungless, M.A. Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proc. Natl. Acad. Sci. USA 106, 4894-4899 (2009).
49. Budygin, E.A. et al. Aversive stimulus differentially triggers subsecond dopamine release in reward regions. Neuroscience 201, 331-337 (2012).
50. Becerra, L. & Borsook, D. Signal valence in the nucleus accumbens to pain onset and offset. Eur. J. Pain 12, 866-869 (2008).
51. Baliki, M.N., Geha, P.Y., Fields, H.L. & Apkarian, A.V. Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain. Neuron 66, 149-160 (2010).
52. Johansen, J.P. & Fields, H.L. Glutamatergic activation of anterior cingulate cortex produces an aversive teaching signal. Nat. Neurosci. 7, 398-403 (2004).
53. Wang, J.Y., Luo, F., Chang, J.Y., Woodward, D.J. & Han, J.S. Parallel pain processing in freely moving rats revealed by distributed neuron recording. Brain Res. 992, 263-271 (2003).
54. LaGraize, S.C., Labuda, C.J., Rutledge, M.A., Jackson, R.L. & Fuchs, P.N. Differential effect of anterior cingulate cortex lesion on mechanical hypersensitivity and escape/avoidance behavior in an animal model of neuropathic pain. Exp. Neurol. 188, 139-148 (2004).
55. Johansen, J.P., Fields, H.L. & Manning, B.H. The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc. Natl. Acad. Sci. USA 98, 8077-8082 (2001).
56. Rainville, P., Duncan, G.H., Price, D.D., Carrier, B. & Bushnell, M.C. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 277, 968-971 (1997).
57. Villemure, C., Laferriere, A.C. & Bushnell, M.C. The ventral striatum is implicated in the analgesic effect of mood changes. Pain Res. Manag. 17, 69-74 (2012).
58. Latremoliere, A. & Woolf, C.J. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J. Pain 10, 895-926 (2009).
59. Gjerstad, A.C., Wagner, K., Henrichsen, T. & Storm, H. Skin conductance versus the modified COMFORT sedation score as a measure of discomfort in artificially ventilated children. Pediatrics 122, e848-e853 (2008).
60. Kender, R.G., Harte, S.E., Munn, E.M. & Borszcz, G.S. Affective analgesia following muscarinic activation of the ventral tegmental area in rats. J. Pain 9, 597-605 (2008).
61. Sotocinal, S.G. et al. The Rat Grimace Scale: a partially automated method for quantifying pain in the laboratory rat via facial expressions. Mol. Pain 7, 55 (2011).
62. King, C.D., Devine, D.P., Vierck, C.J., Mauderli, A. & Yezierski, R.P. Opioid modulation of reflex versus operant responses following stress in the rat. Neuroscience 147, 174-182 (2007).
63. LaBuda, C.J. & Fuchs, P.N. A behavioral test paradigm to measure the aversive quality of inflammatory and neuropathic pain in rats. Exp. Neurol. 163, 490-494 (2000).
64. Anderson, E.M. et al. Use of the Operant Orofacial Pain Assessment Device (OPAD) to measure changes in nociceptive behavior. J. Vis. Exp. doi:10.3791/50336 (2013).
65. Martin, T.J., Kim, S.A. & Eisenach, J.C. Clonidine maintains intrathecal self-Administration in rats following spinal nerve ligation. Pain 125, 257-263 (2006).
66. Ewan, E.E. & Martin, T.J. Analgesics as reinforcers with chronic pain: evidence from operant studies. Neurosci. Lett. 557A, 60-64 (2013).
67. Navratilova, E., Xie, J.Y., King, T. & Porreca, F. Evaluation of reward from pain relief. Ann. NY Acad. Sci. 1282, 1-11 (2013).
68. Sufka, K.J. Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain. Pain 58, 355-366 (1994).
69. Qu, C. et al. Lesion of the rostral anterior cingulate cortex eliminates the aversiveness of spontaneous neuropathic pain following partial or complete axotomy. Pain 152, 1641-1648 (2011).
70. Okun, A. et al. Transient inflammation-induced ongoing pain is driven by TRPV1 sensitive afferents. Mol. Pain 7, 4 (2011).
71. Okun, A. et al. Afferent drive elicits ongoing pain in a model of advanced osteoarthritis. Pain 153, 924-933 (2012).
72. De Felice, M. et al. Capturing the aversive state of cephalic pain preclinically. Ann. Neurol. 74, 257-265 (2013).
73. He, Y., Tian, X., Hu, X., Porreca, F. & Wang, Z.J. Negative reinforcement reveals non-evoked ongoing pain in mice with tissue or nerve injury. J. Pain 13, 598-607 (2012).
74. Davoody, L. et al. Conditioned place preference reveals tonic pain in an animal model of central pain. J. Pain 12, 868-874 (2011).
75. Park, H.J. et al. Persistent hyperalgesia in the Cisplatin-treated mouse as defined by threshold measures, the conditioned place preference paradigm, and changes in dorsal root Ganglia activated transcription factor 3: the effects of gabapentin, ketorolac, and etanercept. Anesth. Analg. 116, 224-231 (2013).
76. Xie, J.Y. et al. Activation of mesocorticolimbic reward circuits for assessment of relief of ongoing pain: A potential biomarker of efficacy. Pain 155, 1659-1666 (2014).
77. Wiech, K. & Tracey, I. The influence of negative emotions on pain: behavioral effects and neural mechanisms. Neuroimage 47, 987-994 (2009).
78. Atlas, L.Y. & Wager, T.D. How expectations shape pain. Neurosci. Lett. 520, 140-148 (2012).
79. Tracey, I. Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans. Nat. Med. 16, 1277-1283 (2010).
80. Eippert, F., Finsterbusch, J., Bingel, U. & Buchel, C. Direct evidence for spinal cord involvement in placebo analgesia. Science 326, 404 (2009).
81. Fields, H. State-dependent opioid control of pain. Nat. Rev. Neurosci. 5, 565-575 (2004).
82. Watson, A. et al. Placebo conditioning and placebo analgesia modulate a common brain network during pain anticipation and perception. Pain 145, 24-30 (2009).
83. Scott, D.J. et al. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch. Gen. Psychiatry 65, 220-231 (2008).
84. Scott, D.J. et al. Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 55, 325-336 (2007).
85. Zubieta, J.K. et al. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J. Neurosci. 25, 7754-7762 (2005).
86. Wager, T.D., Davidson, M.L., Hughes, B.L., Lindquist, M.A. & Ochsner, K.N. Prefrontal-subcortical pathways mediating successful emotion regulation. Neuron 59, 1037-1050 (2008).
87. Lanz, S., Seifert, F. & Maihofner, C. Brain activity associated with pain, hyperalgesia and allodynia: an ALE meta-Analysis. J. Neural Transm. 118, 1139-1154 (2011).
88. Altier, N. & Stewart, J. The role of dopamine in the nucleus accumbens in analgesia. Life Sci. 65, 2269-2287 (1999).
89. Lorenz, J. et al. A unique representation of heat allodynia in the human brain. Neuron 35, 383-393 (2002).
90. Wiech, K. et al. Modulation of pain processing in hyperalgesia by cognitive demand. Neuroimage 27, 59-69 (2005).
91. Seymour, B. et al. Opponent appetitive-Aversive neural processes underlie predictive learning of pain relief. Nat. Neurosci. 8, 1234-1240 (2005).
92. Apkarian, A.V. The brain in chronic pain: clinical implications. Pain Manag. 1, 577-586 (2011).
93. Seminowicz, D.A. et al. MRI structural brain changes associated with sensory and emotional function in a rat model of long-term neuropathic pain. Neuroimage 47, 1007-1014 (2009).
94. May, A. Chronic pain may change the structure of the brain. Pain 137, 7-15 (2008).
95. Geha, P.Y. et al. The brain in chronic CRPS pain: abnormal gray-white matter interactions in emotional and autonomic regions. Neuron 60, 570-581 (2008).
96. Harris, R.E. et al. Decreased central mu-opioid receptor availability in fibromyalgia. J. Neurosci. 27, 10000-10006 (2007).
97. Wood, P.B. et al. Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study. J. Pain 8, 51-58 (2007).
98. Rodriguez-Raecke, R., Niemeier, A., Ihle, K., Ruether, W. & May, A. Brain gray matter decrease in chronic pain is the consequence and not the cause of pain. J. Neurosci. 29, 13746-13750 (2009).
99. Seminowicz, D.A. et al. Effective treatment of chronic low back pain in humans reverses abnormal brain anatomy and function. J. Neurosci. 31, 7540-7550 (2011).
100. Baliki, M.N. et al. Corticostriatal functional connectivity predicts transition to chronic back pain. Nat. Neurosci. 15, 1117-1119 (2012).
101. Neugebauer, V., Galhardo, V., Maione, S. & Mackey, S.C. Forebrain pain mechanisms. Brain Res. Rev. 60, 226-242 (2009).
102. Singh, G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am. J. Med. 105, 31S-38S (1998).
103. Wager, T.D. et al. An fMRI-based neurologic signature of physical pain. N. Engl. J. Med. 368, 1388-1397 (2013).
104. Yen, C.P. et al. Stereotactic bilateral anterior cingulotomy for intractable pain. J. Clin. Neurosci. 12, 886-890 (2005).
105. Foltz, E.L. & White, L.E. Jr. Pain "relief" by frontal cingulumotomy. J. Neurosurg. 19, 89-100 (1962).
106. Mohseni, H.R. et al. MEG can map short and long-term changes in brain activity following deep brain stimulation for chronic pain. PLoS ONE 7, e37993 (2012).
107. Chapin, H., Bagarinao, E. & Mackey, S. Real-time fMRI applied to pain management. Neurosci. Lett. 520, 174-181 (2012).
108. Apkarian, A.V., Hashmi, J.A. & Baliki, M.N. Pain and the brain: specificity and plasticity of the brain in clinical chronic pain. Pain 152, S49-S64 (2011).
109. Gear, R.W. & Levine, J.D. Nucleus accumbens facilitates nociception. Exp. Neurol. 229, 502-506 (2011).